We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+34.4%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$3.43B
AUM Growth
+$283M
Cap. Flow
-$809M
Cap. Flow %
-23.57%
Top 10 Hldgs %
38.81%
Holding
112
New
24
Increased
11
Reduced
35
Closed
19

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$67.2M
2
LRMR icon
Larimar Therapeutics
LRMR
+$59.9M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$29.8M
4
GBIO
Generation Bio
GBIO
+$26.4M
5
RNAM
Avidity Biosciences
RNAM
+$25.3M

Top Sells

Rank Stock Value
1
AHCO icon
AdaptHealth
AHCO
+$264M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$168M
3
QTTB icon
Q32 Bio
QTTB
+$62.7M
4
ABMD
Abiomed Inc
ABMD
+$54.6M
5
IMMU
Immunomedics Inc
IMMU
+$45.2M

Sector Composition

Rank Sector Weight
1 Healthcare 65.56%
2 Financials 0.55%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
26
Arvinas
ARVN
$517M
$33.8M 0.99%
1,008,656
-204,266
-17% -$8.67M
GKOS icon
27
Glaukos
GKOS
$9.21B
$33.6M 0.98%
874,000
+356,018
+69% +$13.3M
BPMC
28
DELISTED
Blueprint Medicines
BPMC
$31.6M 0.92%
405,386
-52,582
-11% -$3.56M
FATE icon
29
Fate Therapeutics
FATE
$324M
$31.4M 0.91%
913,775
-703,218
-43% -$21M
SILK
30
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$31.2M 0.91%
744,998
-603,002
-45% -$23.2M
ISEE
31
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$29.4M 0.86%
5,767,409
+3,500,000
+154% +$14.6M
BDSI
32
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$28.5M 0.83%
6,545,500
+361,257
+6% +$1.62M
CNST
33
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$26.3M 0.76%
873,890
-80,210
-8% -$2.89M
DCPH
34
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$25.2M 0.73%
421,679
-167,806
-28% -$8.98M
GBIO
35
DELISTED
Generation Bio
GBIO
$24.9M 0.73%
+118,622
New +$26.4M
RNAM
36
DELISTED
Avidity Biosciences
RNAM
$24.8M 0.72%
+877,011
New +$25.3M
ADCT icon
37
ADC Therapeutics
ADCT
$172M
$23.4M 0.68%
+500,000
New +$19M
DBVT
38
DBV Technologies
DBVT
$870M
$22.6M 0.66%
515,416
-5,553
-1% -$284K
BDTX icon
39
Black Diamond Therapeutics
BDTX
$103M
$22.6M 0.66%
536,001
– –
AHCO icon
40
AdaptHealth
AHCO
$1.49B
$22.4M 0.65%
1,389,341
-15,810,547
-92% -$264M
LGVW.U
41
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
$22.2M 0.65%
+2,200,000
New +$22.1M
FUSN
42
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$22M 0.64%
+1,257,000
New +$21.9M
MOH icon
43
Molina Healthcare
MOH
$11.7B
$21.4M 0.62%
120,245
-44,755
-27% -$7.62M
FOLD
44
DELISTED
Amicus Therapeutics
FOLD
$21.4M 0.62%
1,416,000
-1,837,960
-56% -$22.4M
BCRX icon
45
BioCryst Pharmaceuticals
BCRX
$2.36B
$21.2M 0.62%
4,456,519
-196,407
-4% -$784K
VAPO
46
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$21.2M 0.62%
64,646
-4,945
-7% -$1.04M
ALXN
47
DELISTED
Alexion Pharmaceuticals
ALXN
$20.9M 0.61%
+186,000
New +$19.7M
MRTX
48
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$20.5M 0.6%
179,885
-62,315
-26% -$6.04M
CSII
49
DELISTED
Cardiovascular Systems, Inc.
CSII
$20.5M 0.6%
+650,000
New +$24.3M
SLQT icon
50
SelectQuote
SLQT
$127M
$19M 0.55%
+750,000
New +$20.1M
1
2
3 4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q2 2020 Portfolio in Review

As of Q2 2020, Deerfield Management held 112 positions worth $3.43B, up 9% from $3.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Deerfield Management withdrew a net $809M in Q2 2020, closing 19 positions and reducing 35 holdings. Its most notable exit was Q32 Bio, an estimated $62.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 72% a quarter earlier, followed by Financials and Technology.

Against the trend, Deerfield Management opened a new position in Hologic worth $78.1M.

  • Deerfield Management's largest Q2 2020 buy was Hologic: 1,370,186 shares worth $78.1M.
  • Deerfield Management added most to MyoKardia, Inc. Common Stock in Q2 2020, an estimated $29.8M increase.
  • Deerfield Management's biggest Q2 2020 reduction was AdaptHealth, cutting an estimated $264M.
  • Deerfield Management fully exited Q32 Bio in Q2 2020, selling an estimated $62.7M.
  • Deerfield Management's ten largest holdings make up 39% of its $3.43B portfolio in Q2 2020.
  • Deerfield Management opened 24 new positions and closed 19 in Q2 2020.
  • Deerfield Management's portfolio value rose 9% quarter-over-quarter to $3.43B.

Based on Deerfield Management's 13F filing for Q2 2020, filed 14 Aug 2020.